Vital Biopharmaceutical Insights and Analytics

for Experts from Experts

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Search Reports


See which reports have been searched on the most.


In the Spotlight

Join us in New York

This exciting one-day seminar provides attendees with a unique opportunity to hear in-depth analysis of hot topics and trends concerning global biosimilars while engaging directly with Decision Resources Group analysts.

View the Agenda  |  Meet our expert speakers



Recent Reports [ view all ]

  • What Are the U.S. Market Access and Prescribing Hurdles for the Growing Number of LAMA- and LABA-Containing Competitors in the COPD Market?

    The U.S. market for chronic obstructive pulmonary disease (COPD) therapies consists entirely of symptomatic treatments,... Read More

  • U.S. Treasury Department Tightens Rules Surrounding Tax Inversions

    New rule changes have already halted one deal within the pharmaceutical sector. Read More

  • Non-Small-Cell Lung Cancer - 2014

    Last Updated 20 October 2014
    Biomarker- and histology-driven prescribing is standard practice in the... Read More

Decision Resources Group brands include: